Clinical trial digital twin service Unlearn.AI raises $50M – TechCrunch

TECHCRUNCH, 19/04/2022

Partagé par : 

Beesens TEAM

Clinical trial digital twin service Unlearn.AI raises $50M – TechCrunch

"The idea of digital twins — digital representations of humans built with computer models — for medical research is gaining traction in private and academic sectors. With predictive simulation technology, some experts say that digital twins have the potential to improve healthcare by assessing health risks before a disease becomes symptomatic, helping clinicians determine, for example, when (and whether) to intervene.

A future where doctors can simulate the effects of all possible treatments on patients’ digital twins to determine the most effective course is admittedly ambitious. That’s perhaps why Unlearn.AI, a startup which today announced that it raised $50 million in a Series B funding round, started with clinical trials. Unlearn’s digital twin product replicates the characteristics of patients in trials to enable what the company claims are smaller, faster studies, built on a combination of AI and historical data.

“We use data combined from a large number of previously-run clinical trials. Our product is not an AI model — it’s a clinical trial,” CEO Charles Fisher told TechCrunch via email. “The wait for vaccine development [during the pandemic] meant that every journalist and most informed consumers became painfully aware of the need to speed up clinical trials while doing them safely … [While there] are other companies interested in using real-world data to make trials faster or better, there are no direct competitors with a direct regulatory pathway to using their technologies in [late-stage] clinical trials.”..." Lire la suite